Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Urology

Get Updates

Urology research articles, Urology research article, Urology journals, Urology journal, Urology articles, Research on Breast cancer, Urology



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • -
  • The Editor in...
  • -
  • Interview with Gene Regulation and Systems Biology editorial board member Dr Frederick Domann
  • - 20/Jul/2010
  • Author interview with Dr Sanjoy K. Bhattacharya
  • - 15/Jul/2010
  • Author interview with Dr Leonid Omelyanchuk
  • - 15/Jul/2010
  • Author interview with Dr Esther Uña Cidón
  • - 14/Jul/2010
  • Author interview with Dr Daniel Curcio
  • - 14/Jul/2010
  • Author interview with Dr Michael Wong
  • - 14/Jul/2010
  • Author interview with Dr Thomas Ostermann
  • - 13/Jul/2010
  • Author interview with Dr Nicolas Carels
  • - 13/Jul/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 12/Jul/2010
  • Author interview with Dr Ross Grant
  • - 08/Jul/2010
  • Author interview with Dr Mirna Waked
  • - 08/Jul/2010
  • Interview with Organic Chemistry Insights editorial board member Dr Uddhav Kelavkar
  • - 02/Jul/2010
  • Author interview with Dr Shailesh Gupta
  • - 21/Jun/2010
  • Interview with Clinical Medicine Insights: Oncology editorial board member Prof. M. Wasif Saif
  • - 18/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr William CS Cho
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
28
Articles published:
1
Comments:
25
Blog entries:

Journal: Clinical Medicine Insights: Urology

Editor in Chief: Xiangyi Lu   |   Table of contents   |   33118 views
Get Updates
Get Updates
Get Updates
Abstract
Full-text PDF

Muscarinic Receptor Antagonists, the Overactive Bladder and Efficacy against Urinary Urgency     (13/May/2010)


The overactive bladder (OAB) is a debilitating condition in which patients suffer from urinary urgency, frequency and nocturia with or without urge urinary incontinence. The mainstay of pharmacotherapy for OAB is muscarinic receptor antagonists, which have been shown to be effective treatments for the symptoms of OAB. The mechanism underlying...


Abstract
Full-text PDF

Transdermal Oxybutynin: What Role in the Management of Overactive Bladder?     (11/May/2010)


Overactive bladder (OAB), a bothersome condition that is frequently associated with incontinence, commonly affects middle-aged and elderly people. OAB not only has a negative effect on physical and mental well-being but also accounts for billions of dollars in health care costs and lost productivity. Although OAB can be treated effectively...


Abstract
Pay-per-view

Treatment of Overactive Bladder Symptoms with Extended Release Fesoterodine Fumarate     (09/Apr/2010)


Fesoterodine extended-release (brand name Toviaz) is a new competitive muscarinic receptor antagonist labeled for the treatment of overactive bladder (OAB). Here we have undertaken a substantial update to a systematic review evaluating the effects of fesoterodine in the treatment of OAB. Our results indicate that fesoterodine was found to have...


Abstract
Full-text PDF

Prostate Cancer: Value of Transrectal Computed Ultrasound Tomography (TRCUT) in Targeted Biopsy Guidance when the Repeat or Random Biopsies Indicated: Early Experience     (23/Mar/2010)


Purpose: To evaluate the feasibility of transrectal computed ultrasound tomography (TRCUT) in localization and targeted biopsy for men who have been shown to be negative in the first biopsy guided by two-dimensional transrectal ultrasound (2D TRUS) but continue to have figures suggestive of prostate cancer, so as to minimize with...


Abstract
Full-text PDF

Introductory Editorial     (10/Feb/2010)


Introductory Editorial by Dr Karna Dev Bardhan


Article: Efficacy and Safety of Cinacalcet in Chronic Kidney Disease Stage III and IV
Full-text PDFAbstract

Efficacy and Safety of Cinacalcet in Chronic Kidney Disease Stage III and IV     (22/Dec/2009)


Treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) stage III and IV with vitamin D sterols is useful to maintain optimal parathyroid hormone (PTH) levels and thereby, reduces the severity of bone abnormalities caused by high PTH levels. However, it should be borne in mind that serum calcium (Ca) levels may easily increase as bone turnover is easily suppressed due to diffuse or early nodular parathyroid tissue in these patients. Furthermore, an...


Abstract
Full-text PDF

Hydronephrosis in Infants and Children: Natural History and Risk Factors for Persistence in Children Followed by a Medical Service     (16/Dec/2009)


Background: Infants with neonatal hydronephrosis and a normal voiding cystourethrogram (VCUG) are presumed to have ureteropelvic junction obstruction (UPJO). There is little current information about the natural history of children with hydronephrosis or clinical factors that predict resolution of the radiological abnormality. Objective: To determine the time course until spontaneous resolution...


Abstract
Pay-per-view

Pharmacotherapy Update on the Treatment of Overactive Bladder Syndrome: Focus on Fesoterodine     (24/Nov/2009)


Overactive bladder is a highly prevalent condition that affects both males and females. The risk of developing overactive bladder increases with aging. There appear to be multiple etiologies for overactive bladder. Antimuscarinic agents have been the main-stay for pharmacologic treatment of overactive bladder. Their role is thought to be via...


Abstract
Full-text PDF

Time Course Analysis of Aminoglycoside-Induced Elevation of Serum Creatinine     (22/Oct/2009)


Objective: The present study aimed to determine the time course of aminoglycoside-induced serum creatinine (SCr) elevation and compare that in patients treated with amikacin (AK) and those treated with gentamicin (GM). Methodology: A one-year, non-interventional prospective study of patients with normal baseline renal function and were administered either GM or AK....


Abstract
Full-text PDF

Cinacalcet HCl Treatment in Patients with Chronic Kidney Disease Stage 3–4     (09/Oct/2009)


It has been clarified in patients with CKD stage 3–4, cinacalcet can reduce PTH levels without severe adverse events, however calcium levels significantly decrease and phosphorus levels increase. Increase of serum phosphorus level by cinacalcet in patients with CKD stage 3–4 is a problematic issue. Undesirable decreases in serum calcium...


Abstract
Full-text PDF

Treatment of Anemia Associated with Chronic Kidney Disease with Methoxy Polyethylene Glycol-Epoetin Beta     (09/Oct/2009)


Anemia resulting from a relative deficiency of erythropoietin commonly complicates chronic kidney disease (CKD). With the introduction of recombinant erythropoietin two decades ago, there has been a dramatic reduction in the need for blood transfusions in CKD patients. Epoetin alpha is a first generation erythropoiesis stimulating agent (ESA) that needs...


Abstract
Full-text PDF

In vitro Efficacy of Ureteral Catheters Impregnated with Ciprofloxacin, N-acetylcysteine and their Combinations on Microbial Adherence     (01/Oct/2009)


Background: Ureteral catheters are valuable indispensable devices may readily acquire biofilms on the inner or outer surfaces. This study evaluated the efficacies of ureteral catheters impregnated with ciprofloxacin, N-acetylcysteine each alone and in combination on microbial adherence. Methods: Antimicrobial durability of ureteral catheters coated, through instant dip method, with ciprofloxacin were...


Abstract
Full-text PDF

Novel Biomarkers for the Diagnosis of Urinary Tract Infection - A Systematic Review     (05/Aug/2009)


Urinary tract infections (UTIs) are associated with significant morbidity. We rely on clinical presentation, urinalysis, and urine culture to diagnose UTI. To differentiate between lower UTI and pyelonephritis, we depend on the clinical presentation. In the extremes of age and in immunocompromised individuals, clinical presentation is often atypical posing a...


Abstract
Full-text PDF

Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report     (30/Jul/2009)


Sarcomatoid carcinoma is a rare tumor of the urinary bladder accounting for less than 0.5% of all primary urinary bladder tumors. Since the patients were presented with large tumor with extended stages, outcome was found to be poor. In order to improve local control, adjuvant local treatment may be practical....


Abstract
Full-text PDF

Pharmacotherapy of Complicated Urinary Tract and Intra-abdominal Infections with Doripenem     (15/Jul/2009)


Due to the growing rate of multi-drug resistant bacteria in complicated infections, the need for new broad-spectrum antimicrobials is paramount. Doripenem, a new addition to the intravenous carbapenem class, has recently been approved for the treatment of complicated lower urinary tract infections and/or pyelonephritis (cUTI) and complicated intra-abdominal infections (cIAI)...


Abstract
Full-text PDF

Carcinoma En Cuirasse of Scrotum—Metastatic Malignancy from A Lung Primary     (01/May/2009)


A 69 year old male who presented with painful, swollen and inflamed scrotum is presented as a unique case report. He was initially treated as a case of infection and was subject to further investigation due to poor response to antibiotics. CT scan showed thickened scrotal wall and an incision...


Abstract
Full-text PDF

Photodynamic Diagnosis For Superficial Bladder Cancer: do All Risk-Groups Profit Equally From Oncological and Economic Long-Term Results?     (30/Apr/2009)


Objective: Photodynamic diagnosis (PDD) of superficial bladder cancer decreases recurrence rates. We present oncological results of a randomized, prospective study, comparing transurethral resection (TUR) performed under conventional white light (WL) with PDD. The follow-up period is the longest reported to date. As costs might be reimbursed by prolonged recurrence-free survival...


Abstract
Full-text PDF

IgA Nephropathy: A Twenty Year Retrospective Single Center Experience     (18/Feb/2009)


Jacob Rube1, Alexandra Peyser1, Freya Tarapore1, Bari Scheckner1, Rachel Frank RN CNN1, Suzanne Vento RN1, Cathy Hoffman RN1, Douglas Charney2, Elsa Valderamma2, Beatrice Goilav1 and Howard Trachtman11Department of Pediatrics. Division of Nephrology, Schneider Children’s Hospital, New Hyde Park, New York. 2Department of Pathology, North Shore-LIJ Health System, Long Island Campus...


Abstract
Full-text PDF

Melamine Contaminated Food: Serious Threat to Our Health     (29/Jan/2009)


Commentary by Dr Jeanne Adiwinata Pawitan, Department of Histology Faculty of Medicine, University of Indonesia Jl. Salemba 6, Jakarta Pusat, Jakarta, 10430, Indonesia.


Abstract
Full-text PDF

Emerging Risk Factors for Urologic Diseases     (29/Aug/2008)


Modern medicine has brought us many miracle cures. In the 21st century, especially, we are blessed with increasingly powerful disease combating tools, such as functional genomics, proteomics and stem cells. Decades of medical and pharmaceutical research have produced thousands of medicines that allow us to treat and prevent diseases better...


Abstract
Full-text PDF

Estimation of Accurate and New Method for Hemodialysis Dose Calculation     (19/May/2008)


Background: The Kt/V value demonstrates the dose of hemodialysis (HD). However, because of several existing methods for calculating delivered dialysis dose, Kt/V values can, in fact, be different for the same set of pre-/post-dialysis blood urea concentrations. Methods: In the study presented here, another formula was derived for calculating...


Abstract
Full-text PDF

Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy     (16/Apr/2008)


Purpose: The purpose of this Phase II randomized-controlled trial was to evaluate the safety and effect of administering several doses of lycopene to men with clinically localized prostate cancer, on intermediate endpoint biomarkers implicated in prostate carcinogenesis. Methods: Forty-five eligible men with clinically localized prostate cancer were supplemented with...


Abstract
Full-text PDF

Biomarkers in Bladder Cancer: Present Status and Perspectives     (27/Mar/2007)


Wun-Jae Kim1, Soongang Park2 and Yong-June Kim2 1Department of Urology, Chungbuk National University, College of Medicine and Institute for Tumor Research, South Korea. 2Department of Urology, Chungbuk National University, College of Medicine, Cheongju, South Korea.Abstract: Bladder cancers are a mixture of heterogeneous cell populations, and numerous factors are likely to...